#1HYPERFINE Defining the Future of MR Brain Imaging, Empowering Clinicians to Serve Patients Worldwide Corporate Presentation | August 2023 © 2023 Hyperfine, Inc.#2Forward Looking Statements This presentation includes forward-looking statements within the meaning of the federal securities laws, which are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. All forward-looking statements, including, without limitation, those relating to our operating trends and future financial performance, expense management, expectations for hiring, training and adoption, growth in our organization, market opportunity, commercial and international expansion, regulatory approvals, and product development are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the "Risk Factors" section of our most recent periodic filing with the Securities and Exchange Commission. © 2023 Hyperfine, Inc. | Confidential and Proprietary HYPERFINE#3© 2023 Hyperfine, Inc. | Condential and Proprietary Challenges for patients & clinicians with Brain MRI today High cost limits accessibility Complex site requirements and upgrades Scheduling delays lead to longer length of stay Consumption of valuable personnel resources Risk of adverse events -today occurring in 22-46% of cases during transport Maintaining connection to life support equipment Single point in time, unable to monitor change in patient condition $ TOOO O E Sm 4 go 0 M3 as O HYPERFINE#4Point of Care MRI is Poised to Greatly Expand the Existing Imaging Market >100,000 Swoop installation opportunities across hospitals and outpatient care facilities >$28 Billion Total Addressable Market © 2023 Hyperfine, Inc. | Confidential and Proprietary E matachana HYPERFINE#5Introducing Swoop® Point of Care MRI™ Portable, ultra-low-field MRI Clinical Applications in Focus: Critical Care, Pediatrics, Stroke © 2023 Hyperfine, Inc. | Confidential and Proprietary tc. 10000 200kg/440lb MAX AAC000 HYPERFINE www >100 issued patents worldwide R FDA Cleared in 2020 Reimbursed under existing imaging codes: MRI Brain without Contrast: 70551 HYPERFINE#6● ● Swoop Transforms Care by Bringing MRI to the Patient Intensive Care Units 2 PERFINE © 2023 Hyperfine, Inc. | Confidential and Proprietary Swoop produces brain images at the point of care, without requiring patient transport Alternative to CT with less radiation exposure and excellent detection capabilities Improves critical care neuroimaging workflow Aids in the rapid diagnosis and triaging of patients Acute Care Settings ANERO ALCOOGE C HYPERFINE Global Health HYPERFINE#7Clinical Validation and Over 20 Peer-Reviewed Publications across Renowned Journals 66 66 66 Game changer is a good way to put it [...] being able to do the level of sophisticated imaging in an ICU that MRI can provide." Dr. Fady Charbel, MD, FAANS, FACS UIC Hyperfine provides me with an opportunity to acquire the information, to interpret the information, and to make a decision based on the information that's in front of me." Dr. Shahid Nimjee, MD, PhD, FAANS, FAHA OHIO STATE Portable MRI should be used to image any patients in ICUs in any [clinical] setting." Dr. Michael Schulder, MD, FAANS © 2023 Hyperfine, Inc. | Confidential and Proprietary Northwell Health AINR nature communications Science BAA Science Advances, April 2022: Portable, Low-Field MRI Enables Highly Accessible and Dynamic Bedside Evaluation of Ischemic Stroke Imaged 50 confirmed acute ischemic stroke patients; accurately detected infarcts in 45 (90%); captured lesions as small as 4mm American Journal of Neuroradiology, April 2022: Implementation of a Low-Field Portable MRI Scanner in a Resource- Constrained Environment: Our Experience in Malawi Acquired >260 brain scans; concluded use may lead to faster diagnosis and expedited treatment, including in comatose patients in the E.D. and bed- bound patients with sudden onset neurologic deficits Nature Communications, August 2021: Portable, Bedside, Low-Field Magnetic Resonance Imaging for Evaluation of Intracerebral Hemorrhage Imaged >140 patients and correctly identified ICH in over 80% of confirmed cases HYPERFINE#8All Stakeholders Benefit with the Swoop System 1.5 Patients Reduced risk of adverse events during transport Reduced exposure to radiation from CT Greater comfort and convenience Faster diagnosis - Improved quality of care © 2023 Hyperfine, Inc. | Confidential and Proprietary Physicians Expedited time to diagnosis and treatment Discharge patients sooner Improving workflow across radiology, neurology, and intensive care MR Tech & Nursing Staff Better incorporation into workflow by reducing transportation time and risk Ergonomic, intuitive, and user-friendly interface Hospitals Reduced risk of adverse events Improved utilization of resources and personnel Increased revenue from incremental high-field MRI scans and reduced length of patient stay HYPERFINE#9Swoop Value Proposition in Critical Care The Swoop system is ideal for critical care settings to be used as the point of care MR brain imaging system for the critically ill patient. Studies show that clinicians have found Swoop system images useful at the point of care for assessing: Change in patient symptoms with an unknown cause ¹,2,3,4 ● ● ● ● ● ● ● ● Follow-up scans for clinically suspected or known strokes greater than 5mm5 Change in ventricular size with or without intervention2,6 Change in an intraparenchymal hematoma5 Change in extra-axial collection 6 Change in the imaging appearance of infarct³ To follow or confirm stability? Mass effect and potential for midline shift8 © 2023 Hyperfine, Inc. | Confidential and Proprietary 1. doi:10.1001/jamaneurol.2020.3263 2. doi:10.1016/j.resuscitation.2022.05.002 3. doi:10.1148/radiol.211721 4.doi:10.1097/CCE.0000000000000306 22 90 10:30 52 15. 520 7.13-- Off Off 70. 25 46 5. doi:10.1038/s41467-021-25441-6 6. doi:10.1136/archdischild-2022-324200 7. doi:10.1126/sciadv.abm3952 8. doi:10.1038/s41598-021-03892-7 AAQQQ orange quanta HYPERFINE#10Critical Care Provides a Sizeable Opportunity ~2700 US Hospitals with ICU's © 2023 Hyperfine, Inc. | Confidential and Proprietary ~115 Neuro ICU's H H H B ~1500 Med-Surg ICU's 11 # # B W m B W M W ~286 ECMO centers ~344 Pediatric ICU's ~1000 Neonatal ICU'S#11Improved Neuroimaging Workflow with Swoop in Critical Care Conventional MRI² Hyperfine Swoop 1.1¹ to 11.7 hours² Step 1 Wait in ICU Step 11 > Step 12 $1.99 > Step 2 > Step 3 > Step 4 > 0.5¹ to 5.3 hours² Step 1 Prepare patient Step 13 > Step 14 > Step 15 o Step 2 Run exam Step 5 Arrange transport staff > Step 6 > Step 7 > Step 8 > Step 16 > Step 17 Step 3 View images Step 9 Wait in MRI corridor Step 18 > Step 19 > Step 20 Step 10 Step 21 Wait for scan interpretation 55% Time reduction² 20+ Steps 3 Steps © 2023 Hyperfine, Inc. | Confidential and Proprietary 1) Mazurek, M.H., Cahn, B.A., Yuen, M.M. et al. Portable, bedside, low-field magnetic resonance imaging for evaluation of intracerebral hemorrhage. Nat Commun 12, 5119 (2021). https://doi.org/10.1038/s41467-021-25441-6 2) Kuoy et al. Point-of-Care Brain MRI: Preliminary Results from a Single-Center Retrospective Study. Radiology 2022 https://doi.org/10.1148/radiol.211721#12Innovative and Agile Engine to Expand Clinical Applications Software innovation, image quality, product iterations $ Lower cost of goods Improved usability and integration into workflow Optimizing Al & Cloud Solutions to improve data management © 2023 Hyperfine, Inc. | Confidential and Proprietary HYPERFINE Critical Care SA K C-spine Stroke Diagnosis Pediatrics Commercial & Clinical Research & Feasibility Other Clinical Use Cases Alzheimer's & MS HYPERFINE#133 Strategic Pillars in Focus Innovation ✓Software upgrades ✓ Deep Learning/Al ✓ Hardware ✓ IP ✓ Partnerships: Viz.ai & BMGF ● Clinical ✓ ACTION PMR (Stroke) ✓ HOPE PMR © 2023 Hyperfine, Inc. | Confidential and Proprietary (Hydrocephalus) ✓ SAFE ECMO MRI ✓ Research Collaborations Pubs and Podium Commercial Expansion ✓ US Focus New Sales & Clinical Teams & Processes ✓ Tech Support & Field Informatics ✓ Streamline Sales Cycle Disciplined spending framework with balanced investment in R&D and SG&A Cash runway extended through end of 2025 HYPERFINE#14Financial Profile Revenue: 2022 Revenue: $6.8 Million 2023 Revenue Guidance: $10 to $14 Million ● ● $0.3 2020 $1.5 2021 $6.8 2022 Revenue in Millions $10 - $14 2023 *2023 bar chart value reflects midpoint of fiscal year 2023 financial guidance, not reported results © 2023 Hyperfine, Inc. | Confidential and Proprietary Cash & Cash Burn: 2022 Year-End Cash and CE: $117.5 Million 2022 Cash Burn: $71 Million 2023 Cash Burn Guidance: $40 to $45 Million ● $71 $40 - $45 2022 2023 Cash Burn in Millions#15Management Team with Proven Track Record of Success © 2023 Hyperfine, Inc. | Confidential and Proprietary Maria Sainz President & Chief Executive Officer Tom Teisseyre Chief Operating Officer Brett Hale Chief Administrative and Chief Financial Officer Dr. Khan Siddiqui Chief Strategy Officer & Chief Medical Officer HYPERFINE#162023 Hyperfine, Inc. | Confidential and Proprietary CARRERA serdadu dann wie ILLIANT. NETFLIX Thank You! THLOST DAUGHTER Hyperfine Swoop 8 The world's first portable MRI system. HYPERFINE HYPR Nasdaq Listed Nasdaq #M a 2022 featur Profes HYPERFINE